Rejected at 5:42 p.m. Feb, 21, 2024 ] by herstein.jacob
Author: shahar
Co-authors: Eli.Tanenbaum
Related Note: 1488765299956
Rationale for change

I have done this card many times - and it is very difficult to memorize

I was thinking how to make this card more orginize and simple to understand , so i suggest my change - please consider the change

I DIDNT change any of the Content!

Rejection reason

No significant improvement being made

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step2_v12::Original_decks::Dorian::neuro::uw #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step2_v12::#Subjects::Hematology::01_Hemostasis::04_Hypercoagulable_State::Warfarin_Skin_Necrosis #AK_Step1_v12::#AMBOSS::#Self_Assessment #AK_Step2_v12::#UWorld::COMLEX::100532 #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#UWorld::Step::1448 #AK_Step2_v12::#AMBOSS::xx0EAR #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::10_Anticoagulation #PANCE::GI::toxic_substance_ingestion #AK_Step1_v12::#UWorld::COMLEX::23821 #AK_Step2_v12::Original_decks::Zanki_Step_2::Neuro::UW_Neuro #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::01_Bleeding_Disorders:_Coagulation_Factor_Disorders_DDx #AK_Step2_v12::#CMS::Pediatrics::Form_08 #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step1_v12::#UWorld::COMLEX::24559 #AK_Step2_v12::#Resources_by_rotation::Neuro::uw::dorian #AK_Step2_v12::#AMBOSS::wN0hWg #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::02_Warfarin #AK_Step2_v12::#Resources_by_rotation::Neuro::uw::zanki #AK_Step2_v12::#SketchyIM::00_Sketchy_Pearls::01_Clinical_Basics::02_Blood_Bank_Review #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::02_Warfarin #AK_Step2_v12::#UWorld::Step::4601 #AK_Step2_v12::#UWorld::COMLEX::101384 #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::03_Specific_toxicity_treatments #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::Original_decks::Dorian::im::uw::neuro #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::01_Warfarin #AK_Step2_v12::#SketchyIM::10_Gastroenterology::Retired_Lesson::05_GI_Bleeding::02_Acute_Upper_GI_Bleed_Esophageal_Non_Varices_Bleeding_[OLD_VERSION] #AK_Step1_v12::#UWorld::Step::709 #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::07_Anticoagulant_Drugs::Extra #AK_Step2_v12::#UWorld::Step::3737 #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::03_Warfarin #PANCE::EOR::Family_med #AK_Step1_v12::#Bootcamp::Biochemistry::12_Vitamins::06_Vitamin_K_Clinical_Implications #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::03_Heparin_vs_warfarin::*Warfarin #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::05_Anticoagulants #AK_Step2_v12::!Shelf::EM #AK_Step2_v12::#AMBOSS::9x0NAR #AK_Step1_v12::#AMBOSS::M5aMkO #AK_Step2_v12::#SketchySurgery::02_Trauma,_Burns,_Critical_Care::04_Head_and_Neck_Trauma::05_Moderate_and_Severe_Traumatic_Brain_Injury_2_Management #AK_Step3_v12::#UWorld::5668 #AK_Step2_v12::#SketchySurgery::02_Trauma,_Burns,_Critical_Care::03_Abdominal_Trauma::01_Hemorrhage_and_Hypovolemic_Shock #AK_Step2_v12::#SketchyIM::10_Gastroenterology::05_GI_Bleeding::01_Acute_Upper_GI_Bleed:_Esophageal_Varices